Merz Pushes Back on US Drug Probe, Citing EU Trade Pact
German Chancellor Friedrich Merz has forcefully rejected a new US tariff investigation into Germany's drug pricing policies, invoking an existing EU trade pact as a bulwark against Washington's claims of 'persistent underpayment' for innovative medicines. This direct pushback comes as the Donald Trump administration escalates its long-running 'America First' campaign, threatening punitive tariffs on German pharmaceutical exports amidst Berlin's own efforts to rein in soaring healthcare spending.















